IMI1 – Call 9

IMI1 – Call 9 was launched on 9 July 2013 with the following topics:

  • WEBAE - leveraging emerging technology for pharmacovigilance
  • Developing innovative therapeutic interventions against physical frailty and sarcopenia (ITI-PF&S) as a prototype geriatric indication
  • Driving re-investment in R&D and responsible use of antibiotics
    (part of the IMI New Drugs for Bad Bugs (ND4BB) programme)
  • Clinical development of antibacterial agents for Gram-negative antibiotic resistant pathogens
    (part of the IMI New Drugs for Bad Bugs (ND4BB) programme)

More information on the topics can be found in IMI’s press release and in the Call text. Other relevant documents, including documents for applicants, the list of expert reviewers, and the independent observers’ reports of the evaluations, can be found on the IMI1 Call documents page.

 

Projects

The projects resulting from IMI1 – Call 9 are:

  • COMBACTE-CARE - Combatting bacterial resistance in Europe - carbapenem resistance
    factsheet | website
  • DRIVE-AB - Driving re-investment in R&D and responsible antibiotic use
    factsheet | website
  • SPRINTT - Sarcopenia and physical frailty in older people: multi‐component treatment strategies
    factsheet | website
  • WEB-RADR - Recognising adverse drug reactions
    factsheet | website